Canadian CANNAINVESTOR Magazine February 2019 | Page 196

272

genetic differences will be used to predict whether a medication will be effective (and degree of effectiveness) for a particular person and to help prevent adverse drug reactions. The field of pharmacogenomics is still in its infancy”.

Aleafia is also:

Expanding international including Austalia.

Recently closed a transaction relating to a national distribution or dispensary model.

Building a 60,000kg outdoor grow faciltiy in Port Perry Ontario.

Partnered with the same post secondary institution as Emblem is partnered with.

Has a relationship with CannTrust.

Reporting record revenues.

In fact, I could dedicate pages to the accomplishments and highlights of both of these companies amd of course that is exactly what the paid promoters do to fill space. I am here to wet your whistle because as always I am not paid to write this case study. Neither ALEF nor EMC have any awareness.

The two companies have very complimentary business lines and philosophies and appear a natural fit. Aleafia has twice now proven to have an eye for undervalued companies off the radar of most. But I also like this M&A because it may just set the stage for what is yet to come … at least maybe. One must never make investment decisions based on “what if” … but it is also always good to project forward.

I believe the post merger Aleafia will be a contender on its own; however, one cannot help but reminded of its relationship with CannTrust and CannTrust in turn has a relationship with Apotex. The consolidation curve cannot be avoided meaning M&A is in its infancy.

You may recall I mentioned Canada House Wellness earlier and would circle back to it. CHV has a large medical clinic and is specifically known for its compassion, its patient advocacy, and its respect and specialized approach to our serice men and women. CHV is also partnered because it is entering the edibles market when legal to do so.

The reference to Quinsam was not at all speculation about Aleafia but rather commentary on my deeming it undervalued and the theme of this case study and my article itself this month – M&A.

Until next time, invest long and prosper and our industry leading suggestions and content will always be there for you as you turn green into gold. But please remember, you are expected to undertake your own due diligence because you are solely responsible for your investment and financial decisions. Our conrent is provided to raise awareness and to facilitate discussion and reseach/analysis only. Our content is static meaning its effective shelf-life could be short lived because of how fast this industry is moving. There is no investment, financial, tax, or medical advice ever being offered, inferred, or suggested.

196